IGC Pharma (IGC) Price to Book (2011 - 2026)

IGC Pharma (IGC) has reported Price to Book for 16 consecutive years, with 4.24 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Price to Book rose 16.57% year-over-year to 4.24 in Q1 2026; TTM through Mar 2026 was 4.24, a 16.57% increase from a year earlier, with the FY2026 full-year figure at 4.24, up 16.57% from the prior year.
• Price to Book was 4.24 for Q1 2026 at IGC Pharma, up from 3.49 in the prior quarter.
• Over five years, Price to Book peaked at 4.74 in Q3 2025 and troughed at 0.92 in Q4 2022.
• A 5-year average of 2.83 and a median of 3.49 in 2025 frame the typical range for Price to Book.
• Across the five-year window, Price to Book sank 53.0% in 2022 and soared 232.37% in 2024, its largest moves.
• Over 5 years, Price to Book stood at 0.92 in 2022, then surged by 113.93% to 1.97 in 2023, then jumped by 112.89% to 4.2 in 2024, then slipped by 16.96% to 3.49 in 2025, then climbed by 21.77% to 4.24 in 2026.
• The last three Price to Book figures came in at 4.24 (Q1 2026), 3.49 (Q4 2025), and 4.74 (Q3 2025), per Business Quant data.